Posted On: 04/27/2014 12:00:03 PM
Post# of 74553
$CELG News
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
What ‘Game of Thrones’ can teach you about money 8:30 a.m. April 5, 2014 - Wallace Witkowski
Biotechs, bonds and more from the 'tempest in a microsecond' 8:32 a.m. April 2, 2014 - Shawn Langlois
Play-it-safe stock investors may take some risk on jobs 8:31 a.m. March 30, 2014 - Wallace Witkowski
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - Russ Britt
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - Russ Britt
The Nasdaq has a message to deliver 1:57 p.m. March 20, 2014 - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:16 p.m. March 14, 2014 - Sue Chang
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
Winning approval for new drugs may get harder, analyst warns 4:56 p.m. Feb. 28, 2014 - Russ Britt
The market puts a few feathers in its cap 2:58 p.m. Jan. 23, 2014 - The Trading Deck
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Celgene's 2014 guidance falls below analyst views 1:19 p.m. Jan. 13, 2014 - MarketWatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 10:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept, Celgene on move amid J.P. Morgan event 10:20 a.m. Jan. 13, 2014 - Victor Reklaitis
Epizyme shares surge 65% after cancer therapy hits milestone 12:06 p.m. Jan. 7, 2014 - Russ Britt
Disappointments? Think Opportunities; Miracle Drug May Be Ailing Gilead: Jim Cramer's Best Blogs 6:00 a.m. April 26, 2014 - TheStreet.com
Celgene working today amid upgrade 3:27 p.m. April 25, 2014 - Seeking Alpha
3 Drugs Stocks Moving The Industry Upward 1:03 p.m. April 25, 2014 - TheStreet.com
Will This Analyst Upgrade Help Celgene (CELG) Stock Today? 9:33 a.m. April 25, 2014 - TheStreet.com
Analysts' Actions: CELG CUDA FITB TWC WFC 8:13 a.m. April 25, 2014 - TheStreet.com
Celgene Corporation (CELG): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. April 25, 2014 - Zacks.com
Cramer's Mad Money - Revenge Of The Nerds (4/24/14) 6:45 a.m. April 25, 2014 - Seeking Alpha
'Mad Money' Lightning Round: United Rentals Is Really Good 6:00 a.m. April 25, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Nerds Rule 8:19 p.m. April 24, 2014 - TheStreet.com
Gilead, Alexion, Biogen, Or Celgene: 1 Mindboggling Metric Identifies The Best Value! 4:57 p.m. April 24, 2014 - Seeking Alpha
Celgene Corporation's CEO Discusses Q1 2014 Results - Earnings Call Transcript 4:17 p.m. April 24, 2014 - Seeking Alpha
Celgene Earnings Grow Year Over Year in Q1 - Analyst Blog 1:27 p.m. April 24, 2014 - Zacks.com
June 6th Options Now Available For Celgene (CELG) 12:14 p.m. April 24, 2014 - TheStreet.com
Jim Cramer Breaks Down Apple (AAPL), Caterpillar (CAT) and American Airlines Group's (AAL) Earnings 12:04 p.m. April 24, 2014 - TheStreet.com
Jim Cramer's Stop Trading: CELG 11:06 a.m. April 24, 2014 - TheStreet.com
Alexion, Celgene Report Contrasting Q1 Earnings 10:39 a.m. April 24, 2014 - Investors Business Daily
Stock Market News for April 24, 2014 - Market News 10:06 a.m. April 24, 2014 - Zacks.com
Celgene licenses Crohns treatment for at least $710M 8:43 a.m. April 24, 2014 - Seeking Alpha
Celgene's Revenue Rises on Higher Sales of Cancer Drug Revlimid 8:31 a.m. April 24, 2014 - The Wall Street Journal Interactive Edition
More on Celgene Q1 results 8:04 a.m. April 24, 2014 - Seeking Alpha
Celgene Corporation to Present at Investor Conferences in May 8:30 a.m. April 25, 2014 - BusinessWire - BZX
Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Celgene Acquires Late-Stage Product for Crohn’s Disease and Other Gastrointestinal Disorders 7:33 a.m. April 24, 2014 - BusinessWire - BZX
Upcoming Earnings Announcements -- Research on Superior Energy Services, Celgene, Penn National Gaming, and PerkinElmer 12:32 p.m. April 22, 2014 - PR Newswire - PRF
Healthcare Companies Report Product Availability, Earning Release Schedules, Event, and Stock Movements - Analyst Notes on Celgene, Vanda, Chelsea Therapeutics, Neurocrine Biosciences, and USANA 8:00 a.m. April 14, 2014 - PR Newswire - PRF
BlackBerry CEO May Consider Exiting Handset Business; Celgene Corporation Favored over Natco in Pre-trial 12:43 a.m. April 10, 2014 - ACCESSWIRE
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL BioPharma, and Hemispherx Biopharma 1:20 p.m. April 8, 2014 - PR Newswire - PRF
Celgene Corporation Sued by Mylan Inc.; GRUBHUB Soars on its First Day of Trading 12:10 a.m. April 7, 2014 - ACCESSWIRE
BetterInvesting Magazine Releases June Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use 4:15 p.m. April 4, 2014 - PR Newswire - PRF
Healthcare Companies Report Transactions, Appeals, New Research Findings and Stock Movements - Analyst Notes on Johnson & Johnson, Teva, Celgene, Cara Therapeutics, and OncoMed Pharmaceuticals 8:00 a.m. April 3, 2014 - PR Newswire - PRF
Critical Alerts For News Corp, Gold SPDR, McDonalds, Trina Solar, and Celgene Released By InvestorsObserver 9:31 a.m. April 1, 2014 - PR Newswire - PRF
Celgene Corporation to Announce First Quarter 2014 Results on April 24, 2014 8:30 a.m. April 1, 2014 - BusinessWire - BZX
Adding Multi-Media Materials: OTEZLA® (apremilast) – First Oral Therapy Approved by the U.S. Food and Drug Administration for the Treatment of Adults with Active Psoriatic Arthritis 4:23 p.m. March 24, 2014 - BusinessWire - BZX
Acceleron, Celgene and Collaborators Announce Two Publications in Nature Medicine Describing Sotatercept and ACE-536 Therapeutic Potential in Beta-thalassemia and Myelodysplastic Syndromes 7:30 a.m. March 24, 2014 - BusinessWire - BZX
Oral OTEZLA® (apremilast) Demonstrated Clinically Meaningful and Sustained Improvements in Skin, Nail and Scalp of Adult Patients with Moderate to Severe Plaque Psoriasis 3:05 p.m. March 23, 2014 - BusinessWire - BZX
OTEZLA® (apremilast) – First Oral Therapy Approved by the U.S. Food and Drug Administration for the Treatment of Adults with Active Psoriatic Arthritis 3:40 p.m. March 21, 2014 - BusinessWire - BZX
Momentum Indicators for Health Care Equities -- Research on Arena Pharma, Hemispherx Biopharma, PDL BioPharma and Celgene 8:16 a.m. March 20, 2014 - PR Newswire - PRF
First-of-Its-Kind Multinational Survey Confirms Psoriasis and Psoriatic Arthritis Patients Are Frequently Undertreated or Not Treated at All 8:02 a.m. March 20, 2014 - BusinessWire - BZX
Celgene Reiterates Commitment to Improving Pancreatic Cancer Care in Europe, Through Significant Research and Patient Support Initiatives 4:18 a.m. March 19, 2014 - BusinessWire - BZX
Conference Schedules, Upcoming Marathon Applications, Revised Guidance, and Acquisitions - Analyst Notes on Celgene, Medtronic, Alexion, Quest Diagnostics, and Illumina 8:00 a.m. March 14, 2014 - PR Newswire - PRF
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
What ‘Game of Thrones’ can teach you about money 8:30 a.m. April 5, 2014 - Wallace Witkowski
Biotechs, bonds and more from the 'tempest in a microsecond' 8:32 a.m. April 2, 2014 - Shawn Langlois
Play-it-safe stock investors may take some risk on jobs 8:31 a.m. March 30, 2014 - Wallace Witkowski
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - Russ Britt
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - Russ Britt
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - Russ Britt
The Nasdaq has a message to deliver 1:57 p.m. March 20, 2014 - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:16 p.m. March 14, 2014 - Sue Chang
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
Winning approval for new drugs may get harder, analyst warns 4:56 p.m. Feb. 28, 2014 - Russ Britt
The market puts a few feathers in its cap 2:58 p.m. Jan. 23, 2014 - The Trading Deck
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Celgene's 2014 guidance falls below analyst views 1:19 p.m. Jan. 13, 2014 - MarketWatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 10:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept, Celgene on move amid J.P. Morgan event 10:20 a.m. Jan. 13, 2014 - Victor Reklaitis
Epizyme shares surge 65% after cancer therapy hits milestone 12:06 p.m. Jan. 7, 2014 - Russ Britt
Disappointments? Think Opportunities; Miracle Drug May Be Ailing Gilead: Jim Cramer's Best Blogs 6:00 a.m. April 26, 2014 - TheStreet.com
Celgene working today amid upgrade 3:27 p.m. April 25, 2014 - Seeking Alpha
3 Drugs Stocks Moving The Industry Upward 1:03 p.m. April 25, 2014 - TheStreet.com
Will This Analyst Upgrade Help Celgene (CELG) Stock Today? 9:33 a.m. April 25, 2014 - TheStreet.com
Analysts' Actions: CELG CUDA FITB TWC WFC 8:13 a.m. April 25, 2014 - TheStreet.com
Celgene Corporation (CELG): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. April 25, 2014 - Zacks.com
Cramer's Mad Money - Revenge Of The Nerds (4/24/14) 6:45 a.m. April 25, 2014 - Seeking Alpha
'Mad Money' Lightning Round: United Rentals Is Really Good 6:00 a.m. April 25, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Nerds Rule 8:19 p.m. April 24, 2014 - TheStreet.com
Gilead, Alexion, Biogen, Or Celgene: 1 Mindboggling Metric Identifies The Best Value! 4:57 p.m. April 24, 2014 - Seeking Alpha
Celgene Corporation's CEO Discusses Q1 2014 Results - Earnings Call Transcript 4:17 p.m. April 24, 2014 - Seeking Alpha
Celgene Earnings Grow Year Over Year in Q1 - Analyst Blog 1:27 p.m. April 24, 2014 - Zacks.com
June 6th Options Now Available For Celgene (CELG) 12:14 p.m. April 24, 2014 - TheStreet.com
Jim Cramer Breaks Down Apple (AAPL), Caterpillar (CAT) and American Airlines Group's (AAL) Earnings 12:04 p.m. April 24, 2014 - TheStreet.com
Jim Cramer's Stop Trading: CELG 11:06 a.m. April 24, 2014 - TheStreet.com
Alexion, Celgene Report Contrasting Q1 Earnings 10:39 a.m. April 24, 2014 - Investors Business Daily
Stock Market News for April 24, 2014 - Market News 10:06 a.m. April 24, 2014 - Zacks.com
Celgene licenses Crohns treatment for at least $710M 8:43 a.m. April 24, 2014 - Seeking Alpha
Celgene's Revenue Rises on Higher Sales of Cancer Drug Revlimid 8:31 a.m. April 24, 2014 - The Wall Street Journal Interactive Edition
More on Celgene Q1 results 8:04 a.m. April 24, 2014 - Seeking Alpha
Celgene Corporation to Present at Investor Conferences in May 8:30 a.m. April 25, 2014 - BusinessWire - BZX
Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Celgene Acquires Late-Stage Product for Crohn’s Disease and Other Gastrointestinal Disorders 7:33 a.m. April 24, 2014 - BusinessWire - BZX
Upcoming Earnings Announcements -- Research on Superior Energy Services, Celgene, Penn National Gaming, and PerkinElmer 12:32 p.m. April 22, 2014 - PR Newswire - PRF
Healthcare Companies Report Product Availability, Earning Release Schedules, Event, and Stock Movements - Analyst Notes on Celgene, Vanda, Chelsea Therapeutics, Neurocrine Biosciences, and USANA 8:00 a.m. April 14, 2014 - PR Newswire - PRF
BlackBerry CEO May Consider Exiting Handset Business; Celgene Corporation Favored over Natco in Pre-trial 12:43 a.m. April 10, 2014 - ACCESSWIRE
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL BioPharma, and Hemispherx Biopharma 1:20 p.m. April 8, 2014 - PR Newswire - PRF
Celgene Corporation Sued by Mylan Inc.; GRUBHUB Soars on its First Day of Trading 12:10 a.m. April 7, 2014 - ACCESSWIRE
BetterInvesting Magazine Releases June Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use 4:15 p.m. April 4, 2014 - PR Newswire - PRF
Healthcare Companies Report Transactions, Appeals, New Research Findings and Stock Movements - Analyst Notes on Johnson & Johnson, Teva, Celgene, Cara Therapeutics, and OncoMed Pharmaceuticals 8:00 a.m. April 3, 2014 - PR Newswire - PRF
Critical Alerts For News Corp, Gold SPDR, McDonalds, Trina Solar, and Celgene Released By InvestorsObserver 9:31 a.m. April 1, 2014 - PR Newswire - PRF
Celgene Corporation to Announce First Quarter 2014 Results on April 24, 2014 8:30 a.m. April 1, 2014 - BusinessWire - BZX
Adding Multi-Media Materials: OTEZLA® (apremilast) – First Oral Therapy Approved by the U.S. Food and Drug Administration for the Treatment of Adults with Active Psoriatic Arthritis 4:23 p.m. March 24, 2014 - BusinessWire - BZX
Acceleron, Celgene and Collaborators Announce Two Publications in Nature Medicine Describing Sotatercept and ACE-536 Therapeutic Potential in Beta-thalassemia and Myelodysplastic Syndromes 7:30 a.m. March 24, 2014 - BusinessWire - BZX
Oral OTEZLA® (apremilast) Demonstrated Clinically Meaningful and Sustained Improvements in Skin, Nail and Scalp of Adult Patients with Moderate to Severe Plaque Psoriasis 3:05 p.m. March 23, 2014 - BusinessWire - BZX
OTEZLA® (apremilast) – First Oral Therapy Approved by the U.S. Food and Drug Administration for the Treatment of Adults with Active Psoriatic Arthritis 3:40 p.m. March 21, 2014 - BusinessWire - BZX
Momentum Indicators for Health Care Equities -- Research on Arena Pharma, Hemispherx Biopharma, PDL BioPharma and Celgene 8:16 a.m. March 20, 2014 - PR Newswire - PRF
First-of-Its-Kind Multinational Survey Confirms Psoriasis and Psoriatic Arthritis Patients Are Frequently Undertreated or Not Treated at All 8:02 a.m. March 20, 2014 - BusinessWire - BZX
Celgene Reiterates Commitment to Improving Pancreatic Cancer Care in Europe, Through Significant Research and Patient Support Initiatives 4:18 a.m. March 19, 2014 - BusinessWire - BZX
Conference Schedules, Upcoming Marathon Applications, Revised Guidance, and Acquisitions - Analyst Notes on Celgene, Medtronic, Alexion, Quest Diagnostics, and Illumina 8:00 a.m. March 14, 2014 - PR Newswire - PRF
(0)
(0)
